Mannitol Injection, USP 25 % (Mannitol SOLUTION) 25 %

Mannitol Injection, USP 25% is an intravenous solution used for various medical purposes, including fluid replacement and reducing intracranial pressure. This sterile solution is manufactured by Fresenius Kabi Canada Ltd.

Strength

25 %

Pack Size

50 ML

Manufacturer / TM Owner

FRESENIUS KABI CANADA LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mannitol Injection, USP 25% is commonly used to promote diuresis, which helps the kidneys remove excess fluids and waste from the body. It is also used to reduce intracranial pressure and promote urine output in certain medical conditions. Mannitol is often administered intravenously to achieve these effects.

Side Effects

When administered, Mannitol Injection, USP 25% works by drawing water out of the tissues and into the bloodstream, which can help reduce swelling and pressure. This process can lead to increased urine production, helping to flush out excess fluids and waste products from the body.

Precautions & Warnings

Mannitol Injection, USP 25% should be used with caution in patients with certain medical conditions, such as heart failure or kidney disease. It is important to follow the advice of a healthcare provider when using this solution. Always check the label for any specific warnings or precautions.

Avoid Interactions

Mannitol may interact with certain medications, including diuretics and corticosteroids. It is important to inform your healthcare provider about all medications you are taking before using Mannitol Injection, USP 25%. Additionally, alcohol and other substances may affect the way Mannitol works in the body.

Frequently Asked Questions

Mannitol Injection, USP 25% is used to promote diuresis and reduce intracranial pressure. It helps the kidneys remove excess fluids and waste from the body.

Mannitol Injection, USP 25% is administered intravenously, typically by a healthcare professional in a clinical setting.

Common effects include increased urine production and reduced swelling or pressure in certain areas of the body.

Patients with heart failure, kidney disease, or other serious medical conditions should use Mannitol with caution and under medical supervision.

Yes, Mannitol may interact with diuretics, corticosteroids, and other medications. Always inform your healthcare provider about all medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.